HomeAI · summaries
Storia in 3 fonti
McKesson Buys Precision Medicine to Expand Clinical Research and Commercialization - McKesson (NYSE:MCK)
McKesson will acquire Precision Medicine Group for $2.25 billion, expanding its clinical research and drug commercialization services.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
fiercepharma.com
McKesson strikes $2.25B deal to snap up Precision Medicine Group
McKesson Corporation is expanding its drug development and commercialization capacity to the tune of $2.25 billion. | The healthcare conglomerate ,which ranks eighth on the…
- ·
benzinga.com
McKesson Buys Precision Medicine to Expand Clinical Research and Commercialization - McKesson (NYSE:MCK)
McKesson will acquire Precision Medicine Group for $2.25 billion, expanding its clinical research and drug commercialization services.
